Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 31, 2013Lara D. VeekenOpen Access

Juvenile idiopathic arthritis and malignancy

View Full Paper
Ask AI
Bookmark
Share

Authors

NRNicolino RupertoRoche (Switzerland)AMAlberto MartiniUniversity of Siena

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ruperto et al. (2013) studied this question.

synapsesocial.com/papers/6a8376f8f095d3dbada6d050https://doi.org/10.1093/rheumatology/ket318
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis2008 · 634 citations
  2. 2A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features2011 · 195 citations
  3. 3Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study2010 · 125 citations
  4. 4Use of unlabelled and off licence drugs in children2000 · 43 citations